On your treatment journey, you may find that paying for treatment is one of the challenges you encounter along the way. AfiniTRAC is an insurance support program from Novartis Oncology, the maker of Afinitor. AfiniTRAC can help you navigate the insurance process by helping to:
Simply click to download an enrollment form.
Either you or your doctor can fill out the form. Then, have your doctor sign it and fax it to 1-888-891-4924. AfiniTRAC will contact your doctor about whether or not you are eligible for help.
AfiniTRAC offers support for many kinds of patients, including those with private insurance, Medicare, and even uninsured patients. Programs are available for eligible patients as follows:
For questions, you can call 1-888-5-AfiniTRAC (1-888-523-4648). Click for more information about Afinitor.
Novartis Oncology also offers the Afinitor Co-pay Card Program to insured patients. Eligible patients† will not have to pay a co-pay or co-insurance when picking up their Afinitor prescription.
Afinitor can be obtained from any retail or specialty pharmacy with a prescription. More than 10,000 pharmacies participate in the Afinitor Co-pay Card Program. To confirm that your chosen pharmacy is a participating pharmacy, please call 1-866-347-8537.
Afinitor is a prescription medicine used to treat people with advanced kidney cancer (renal cell carcinoma or RCC) when certain other medicines have not worked (ie, Sutent® [sunitinib] or Nexavar® [sorafenib]).
Important Safety Information
Patients should not take AFINITOR if they are allergic to AFINITOR or to any of its ingredients. Patients should tell their healthcare provider before taking AFINITOR if they are allergic to sirolimus (Rapamune®) or temsirolimus (Torisel®).
AFINITOR can cause serious side effects including lung or breathing problems, infections and kidney failure, which can even lead to death. If patients experience these side effects, they may need to stop taking AFINITOR for a while or use a lower dose. Patients should follow their healthcare provider's instructions.
Lung or Breathing Problems: In some patients, lung or breathing problems may be severe, and can even lead to death. Patients should tell their healthcare provider right away if they have any of these symptoms: new or worsening cough, shortness of breath, chest pain, difficulty breathing or wheezing.
Infections: AFINITOR may make patients more likely to develop an infection, such as pneumonia, or a bacterial, fungal, or viral infection. Viral infections may include reactivation of hepatitis B in people who have had hepatitis B in the past. In some people these infections may be severe, and can even lead to death. Patients may need to be treated as soon as possible. Patients should tell their healthcare provider right away if they have a temperature of 100.5°F or above, chills, or do not feel well. Symptoms of hepatitis B or infection may include the following: fever, skin rash, joint pain and inflammation, tiredness, loss of appetite, nausea, pale stool or dark urine, yellowing of the skin, or pain in the upper right side.
Kidney Failure: AFINITOR may cause kidney failure. In some people this may be severe and can even lead to death. Patients should have tests to check their kidney function before and during their treatment with AFINITOR.
Mouth Ulcers: AFINITOR can cause mouth ulcers and sores. Patients should tell their healthcare provider if they have pain, discomfort, or open sores in their mouth. Their healthcare provider may tell them to use a special mouthwash or mouth gel that does not contain alcohol or peroxide.
Blood Tests: Patients will have regular blood tests before they start AFINITOR and as needed during their treatment. These will include tests to check the patient's blood cell count, kidney and liver function, and blood sugar levels.
Other Medicines/Food and AFINITOR: AFINITOR may affect the way other medicines work, and other medicines can affect how AFINITOR works. Using AFINITOR with other medicines can cause serious side effects. Patients should tell their healthcare provider about all of the medicines they take, including prescription and non-prescription medicines, vitamins, and herbal supplements such as: St. John's Wort and medicine for fungal infections, bacterial infections, tuberculosis, seizures, HIV-AIDS, heart conditions or high blood pressure, and medicines that suppress their immune system. Patients should not drink grapefruit juice or eat grapefruit during their treatment with AFINITOR as it may make the amount of AFINITOR in their blood increase to a harmful level.
Patients should not take AFINITOR tablets which are broken or crushed. Patients should not chew or crush the tablets.
Liver Problems and Other Medical Conditions: The amount of AFINITOR in the blood was increased in patients who had liver problems. Patients should tell their healthcare provider about all their medical conditions including if they have or have had liver problems, diabetes or high blood sugar, high cholesterol levels, infections, hepatitis B, or other medical conditions.
Vaccinations: Patients should tell their healthcare provider if they are scheduled to receive any vaccinations. Patients should not receive a live vaccine or be around people who have recently received a live vaccine during treatment with AFINITOR.
Use in Pregnancy: It is not known if AFINITOR will harm an unborn baby. Women should use effective birth control while using AFINITOR and for 8 weeks after stopping treatment.
Common Side Effects: Common side effects of AFINITOR include mouth ulcers; feeling weak or tired; cough and shortness of breath; diarrhea; skin problems (such as rash, dry skin, and itching); nausea and vomiting; fever; loss of appetite; swelling of arms, hands, feet, ankles, face or other parts of the body; abnormal taste; inflammation of lining of the digestive system; headache; nose bleeds; and pain in arms and legs.
Patients should tell their healthcare provider if they have any side effect that bothers them or does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see Full Prescribing Information for AFINITOR
Sutent®, Rapamune® and Torisel® are registered trademarks of Pfizer Inc.
Nexavar® is a registered trademark of Onyx Pharmaceuticals, Inc. and Bayer HealthCare Pharmaceuticals, Inc.
*The co-pay assistance offer is not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, or similar federal or state programs including any state medical pharmaceutical assistance program, or for residents of the commonwealth of Massachusetts. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this program without notice.
†For private insurance patients only. Support provided for duration of treatment.